Endoscopic and histopathologic gastric changes in chronic users of proton-pump inhibitors;Alterações endoscópicas e histopatológicas gástricas em pacientes usuários crônicos de inibidores de bomba de prótons

Arquivos de Gastroenterologia

Volumn 52, Issue 1, 2015, Pages 59-64

  Camilo, Sílvia Maria Perrone ^a   Almeida, Élia Cláudia de Souza ^a   Miranzi, Benito André Silveira ^b   Silva, Juliano Carvalho ^a   Nomelini, Rosemary Simões ^a   Etchebehere, Renata Margarida ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

Author keywords

Chagas disease; Gastrin; Gastritis; Gastrointestinal endoscopy; Helicobacter pylori; Proton pump inhibitors

Indexed keywords

GASTRIN; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ATROPHY; CELL HYPERPLASIA; CHAGAS DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYP; PROSPECTIVE STUDY; QUESTIONNAIRE; SCAR FORMATION; SEROLOGY; STOMACH BIOPSY; STOMACH DISEASE; STOMACH EROSION; STOMACH MUCOSA; BIOPSY; BLOOD; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; CHAGAS DISEASE; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; STOMACH DISEASES; YOUNG ADULT;

EID: 84929623257     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032015000100013     Document Type: Article

References (27)

1. Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54(12):2617-22.
2. Alqutub AN, Masoodi I. A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy. Ger Med Sci. 2010;2:1-4.
3. Burkitt MD, Varro A, Pritchard DM. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol. 2009;15(1):1-16.
4. Cao H, Qu R, Zhang Z, Kong X, Wang S, Jiang W, et al. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with helicobacter pylori infection in China. Chin Med J (Engl). 2014;127(7):1239-43.
5. Cats A, Schenk BED, Bloemena E, Roosendaal R, Lindeman J, Biemond I. et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000;31(6):684-90.
6. Dias MGM, Dani R, Lima EJM. Farmacoterapia, aparelho digestivo e o paciente geriátrico. In: Dani R. Gastroenterologia essencial. 4th ed. Rio de Janeiro: Guanabara Koogan; 2011. p. 1168-78.
7. Dixon MF, Path FRC, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol. 1996;20(10):1161-81.
8. Eisig JN, Ferreira RPB. Doenças do estômago e duodeno. In: Martins MA, Carrilho FJ, Alves VAF, Carrilho EA, Cerri GG, Wen CL. Clínica médica: volume 4: doenças do aparelho digestivo, nutrição e doenças nutricionais. Barueri: Manole; 2009. p. 96-119.
9. Espugues JV, Marti-Cabrera, M. Seguridad e interaciones de los IBP. Gen. 2010;64(3):221-7.
10. Fossmark R, Jianu CS, Martinsen TC, Qviqstad G, Syversen U, Waldum HL. Serum gastrin and chromogranin a levels in patients with fundic gland polyps caused by long-term proton-pump inhibiton. Scand J Gastroenterol. 2008;43(1):20-4.
11. Freeman HJ. Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World J Gastroenterol. 2008;7(14):1318-20.
12. González EG, Perez GIP, Garza H, Padilha FJB. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol. 2014;20(6):1438-49.
13. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor trerapy. Aliment Pharmacol Ther. 2006;24(9):1341-8.
14. Martín-Echevarría E, Juliá AP, Torralba M, Pereda GA, Dávila PM, Mateos J. et al. Assessing the use of proton pump inhibitors in internal medicine department. Rev Esp Enferm Dig. 2008;100(2):76-81.
15. Menegassi VS, Czeczko LEA, Czeczko LSG, Ioshii SO, Pisani JC, Ramos Jr O. Prevalência de alterações proliferativas gástricas em pacientes com uso crônico de inibidores de bomba de prótons. ABCD, Arq Bras Cir Dig. 2010;23(3):145-9.
16. Ministério da Saúde (Brasil). Elenco oficial dos medicamentos disponibilizados pela rede própria do programa Farmácia Popular do Brasil. [2012]. [cited 2014 May 14]. Available from: http://portalsaude.saude.gov.br/images/pdf/2014/fevereiro/20/ elenco-fp1-20-08-12.pdf
17. Mott CB, Guarita DR, Sipahi AM, Betarello A. Hormônios Gastro-entero-pancreáticos em portadores de Doença de Chagas crônica. Rev Hosp Clin Fac Med Univ São Paulo. 1989;44(2):63-72.
18. Oscanoa Espinoza TJ. Seguridad de los inhibidores de la bomba de protones. Rev Gastroenterol Perú. 2011;31(1):49-55.
19. Owen DA. Stomach. In: Milss SE. Histology for Pathologists. 5. ed. New York: Lippincott Wiliams & Wilkins; 2012. p. 633-46.
20. Raugnunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of próton-pump inhibitors. Aliment Pharmacol Ther. 2005;22(Suppl 1):S55-63.
21. Rotman SR, Bishop TF. Proton pump inhibitor use in the U.S. Ambulatory Setting, 2002-2009. PLoS One. 2013;8(2):1-8.
22. Sanabria C, Pérez-Ferre N, Lecumberri E, Miguel P. Gastrinoma. Endocrinología y Nutrición. 2007;54(Suppl 1):S21-30.
23. Sanduleanu S, Jonkers D, Bruine A, Hameeteman W, Stockbrügger W. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15(3):379-88.
24. Troncon LEA, Barbosa AJA, Romanello LMF, Toppa NH. Antral gastrin cell population in patients with chagasic megaesophagus and megacolon. Braz J Med Biol Res. 1994;27(3):645-53.
25. Wallace JL, Sharkey KA. Farmacoterapia da acidez gástrica, úlceras pépticas e doença do refluxo gastroesofágico. In: Bruton LL, Chabner BA, Knollmann BC. As bases farmacológicas da terapêutica de Goodman e Gilman. 12. ed. Porto Alegre: Artmed; 2012. p. 1309-22.
26. Watanabe N, Seno H, Nakajima T, Yazumi S, Miyamoto S, Matsumoto S. et al. Regression of fundic gland polyps following acquisition of Helicobacter pylori. Gut. 2002;51(5):742-5.
27. Wedmeyer RS, Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Saf. 2014;37(4):201-11.